Organon Stock Pops After Audit Committee Clears Past Biosimilar Purchases
Organon & Co. shares climbed 6% on Friday morning after the company's audit committee, with outside counsel support, completed an independent review and concluded there was no improper conduct related to prior biosimilar purchases from a supplier. The committee reported the review did not identify any issues requiring adjustments to previously issu…